Glaucoma Associates of New York Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial
2000
NCT00570726
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

collagen (1 trial)

mitomycin (mutamycin) (1 trial)

Drugs in Phase 2 Trials (1)

verosudil (1 trial)

Drugs in Phase 1 Trials (1)

ranibizumab (lucentis) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Exfoliation Syndrome (Phase 2)

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 2)

Hypertension (Phase 2)

Ocular Hypertension (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4